BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 11801641)

  • 1. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
    Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
    J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
    Graca L; Thompson S; Lin CY; Adams E; Cobbold SP; Waldmann H
    J Immunol; 2002 Jun; 168(11):5558-65. PubMed ID: 12023351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av; Herber M; Wood KJ; Jones ND
    J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.
    Taylor PA; Noelle RJ; Blazar BR
    J Exp Med; 2001 Jun; 193(11):1311-8. PubMed ID: 11390438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25high regulatory cells in human peripheral blood.
    Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
    J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size.
    Sho M; Yamada A; Najafian N; Salama AD; Harada H; Sandner SE; Sanchez-Fueyo A; Zheng XX; Strom TB; Sayegh MH
    J Immunol; 2002 Oct; 169(7):3744-51. PubMed ID: 12244168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10.
    Annacker O; Pimenta-Araujo R; Burlen-Defranoux O; Barbosa TC; Cumano A; Bandeira A
    J Immunol; 2001 Mar; 166(5):3008-18. PubMed ID: 11207250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking the immunoregulatory mechanisms active during allograft tolerance.
    Sánchez-Fueyo A; Weber M; Domenig C; Strom TB; Zheng XX
    J Immunol; 2002 Mar; 168(5):2274-81. PubMed ID: 11859115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process.
    Karim M; Kingsley CI; Bushell AR; Sawitzki BS; Wood KJ
    J Immunol; 2004 Jan; 172(2):923-8. PubMed ID: 14707064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.
    Grundström S; Cederbom L; Sundstedt A; Scheipers P; Ivars F
    J Immunol; 2003 May; 170(10):5008-17. PubMed ID: 12734345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen.
    Bushell A; Jones E; Gallimore A; Wood K
    J Immunol; 2005 Mar; 174(6):3290-7. PubMed ID: 15749860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation.
    Karim M; Feng G; Wood KJ; Bushell AR
    Blood; 2005 Jun; 105(12):4871-7. PubMed ID: 15713793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.
    Takahashi T; Tagami T; Yamazaki S; Uede T; Shimizu J; Sakaguchi N; Mak TW; Sakaguchi S
    J Exp Med; 2000 Jul; 192(2):303-10. PubMed ID: 10899917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4.
    Liu H; Hu B; Xu D; Liew FY
    J Immunol; 2003 Nov; 171(10):5012-7. PubMed ID: 14607897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
    Masuyama J; Kaga S; Kano S; Minota S
    J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
    Vasu C; Prabhakar BS; Holterman MJ
    J Immunol; 2004 Aug; 173(4):2866-76. PubMed ID: 15295006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.